Plasma exchange (PE)
Evidence-based neurology checklist on plasma exchange (pe): Level A evidenced indications Severe Guillain Barre syndrome (GBS) Severe chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) Level B evidenced indications Lower evidenced indications Pre-procedure investigations…
Level A evidenced indications
- Severe Guillain Barre syndrome (GBS)
- Severe chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Level B evidenced indications
Lower evidenced indications
Pre-procedure investigations
Pre-procedure precautions
Complications of procedure
Complications of vascular access
Acronym
References
- Cortese I, Chaudhry V, So YT, et al. Evidence-based guideline update: plasmapheresis in neurologic disorders. Report of the Therapeutics and Technology Assessment Subcommittee of the American Association of Neurology. Neurology 2011; 76:294-300.
- Osman C, Jennings R, El-Ghariani K, Pinto A. Plasma exchange in neurological disease. Pract Neurol 2020; 20:92-99.
- Sinanović O, Zukić S, Burina A, et al. Plasmapheresis in neurological disorders: six years experience from University Clinical center Tuzla. F1000Res 2017; 6:1234.
- Strasser E. Principles of therapeutic apheresis in neurological disease. Transfus Med Hemother 2023; 50:88-97.
- Shemin D, Briggs D, Greenan M. Complications of therapeutic plasma exchange: a prospective study of 1,727 procedures. J Clin Apher 2007; 22:270-276.
- And 3 more. Subscribe to see the full list
